Identification of a bacteriocin and its cognate immunity factor expressed by Moraxella catarrhalis by Attia, Ahmed S et al.
BioMed  Central
Page 1 of 15
(page number not for citation purposes)
BMC Microbiology
Open Access Research article
Identification of a bacteriocin and its cognate immunity factor 
expressed by Moraxella catarrhalis
Ahmed S Attia1,4, Jennifer L Sedillo1, Todd C Hoopman1,2, Wei Liu2, 
Lixia Liu1, Chad A Brautigam3 and Eric J Hansen*1
Address: 1Department of Microbiology, University of Texas Southwestern Medical Center, Dallas, TX, USA, 2Department of Internal Medicine, 
Pulmonary and Critical Care Medicine, University of Texas Southwestern Medical Center, Dallas, TX, 75390, USA, 3Department of Biochemistry, 
University of Texas Southwestern Medical Center, Dallas, TX, USA and 4Department of Microbiology and Immunology, Faculty of Pharmacy, Cairo 
University, Cairo, Egypt
Email: Ahmed S Attia - ahmed.s.attia@gmail.com; Jennifer L Sedillo - jsedillo@health.usf.edu; 
Todd C Hoopman - todd.hoopman@utsouthwestern.edu; Wei Liu - WeiZ.Liu@utsouthwestern.edu; Lixia Liu - lixia_liu@hotmail.com; 
Chad A Brautigam - Chad.Brautigam@utsouthwestern.edu; Eric J Hansen* - eric.hansen@utsouthwestern.edu
* Corresponding author    
Abstract
Background: Bacteriocins are antimicrobial proteins and peptides ribosomally synthesized by
some bacteria which can effect both intraspecies and interspecies killing.
Results: Moraxella catarrhalis strain E22 containing plasmid pLQ510 was shown to inhibit the
growth of M. catarrhalis strain O35E. Two genes (mcbA and mcbB) in pLQ510 encoded proteins
predicted to be involved in the secretion of a bacteriocin. Immediately downstream from these two
genes, a very short ORF (mcbC) encoded a protein which had some homology to double-glycine
bacteriocins produced by other bacteria. A second very short ORF (mcbI) immediately
downstream from mcbC encoded a protein which had no significant similarity to other proteins in
the databases. Cloning and expression of the mcbI gene in M. catarrhalis O35E indicated that this
gene encoded the cognate immunity factor. Reverse transcriptase-PCR was used to show that the
mcbA,  mcbB,  mcbC, and mcbI  ORFs were transcriptionally linked. This four-gene cluster was
subsequently shown to be present in the chromosome of several M. catarrhalis strains including
O12E. Inactivation of the mcbA, mcbB, or mcbC ORFs in M. catarrhalis O12E eliminated the ability
of this strain to inhibit the growth of M. catarrhalis O35E. In co-culture experiments involving a M.
catarrhalis strain containing the mcbABCI locus and one which lacked this locus, the former strain
became the predominant member of the culture after overnight growth in broth.
Conclusion: This is the first description of a bacteriocin and its cognate immunity factor produced
by M. catarrhalis. The killing activity of the McbC protein raises the possibility that it might serve to
lyse other M. catarrhalis strains that lack the mcbABCI locus, thereby making their DNA available for
lateral gene transfer.
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Background
Moraxella catarrhalis, formerly known as both Neisseria
catarrhalis and Branhamella catarrhalis [1], is a gram-nega-
tive bacterium that can frequently be isolated from the
nasopharynx of healthy persons [2-4]. For many years, M.
catarrhalis was considered to be a harmless commensal [1-
4]. About twenty years ago, it was acknowledged that M.
catarrhalis was a pathogen of the respiratory tract [5], and
since then much evidence has accumulated which indi-
cates that M. catarrhalis causes disease in both adults and
children. M. catarrhalis is one of the three most important
causes of otitis media in infants and very young children
[3,6]. In adults, this bacterium can cause infectious exac-
erbations of chronic obstructive pulmonary disease
(COPD), and one recent study estimates that, in the
United States alone, M. catarrhalis may cause 2 million-4
million infectious exacerbations of COPD annually [7].
The ability of M. catarrhalis to colonize the mucosa of the
upper respiratory tract (i.e., nasopharynx) is undoubtedly
linked to its expression of different adhesins for various
human cells and antigens [8-15]. In addition, this bacte-
rium clearly has the metabolic capability to survive and
grow in this environment in the presence of the normal
flora. A recent study [16] identified a number of different
metabolic pathways encoded by the M. catarrhalis ATCC
43617 genome which could be involved in the coloniza-
tion process. It is likely that M. catarrhalis forms a biofilm
in concert with these other bacteria in the nasopharynx
[17], although only a few M. catarrhalis gene products rel-
evant to biofilm formation have been identified to date
[13,18,19]. Similarly, there is little known about what
extracellular gene products are synthesized by M. catarrh-
alis  and released into the extracellular milieu. A study
from Campagnari and colleagues [15] found that one or
two very large proteins with some similarity to the fila-
mentous hemagglutinin (FhaB) of Bordetella pertussis
could be found in M. catarrhalis culture supernatant fluid.
Using the nucleotide sequence of the genome of M.
catarrhalis  ATCC 43617, Murphy and co-workers [20]
identified a large number (i.e., 348) of proteins that had
signal sequences, among which may be proteins that are
released from the M. catarrhalis cell. Another group
showed that M. catarrhalis culture supernatant fluid con-
tained several different proteins as detected by SDS-PAGE
analysis, but the identity of the individual proteins was
not determined [21].
In the present study, we report the first identification of a
bacteriocin that is produced by M. catarrhalis. Bacteriocins
are proteins or peptides secreted or released by some bac-
teria that can effect both intraspecies and interspecies kill-
ing, and are responsible for some types of bacterial
antagonism [for reviews see [22,23]]. The locus encoding
this peptide bacteriocin was identified initially in a M.
catarrhalis plasmid and subsequently shown to be present
in the chromosome of some M. catarrhalis strains. Four
genes encoding the bacteriocin, relevant secretion factors,
and a host immunity factor were shown to form a polycis-
tronic operon (mcbABCI). This bacteriocin was shown to
be active against M. catarrhalis strains lacking this operon.
Recombinant methods were used to confirm the identity
of the cognate immunity factor which does not resemble
other proteins in the databases. In competitive co-culture
assays, a M. catarrhalis strain expressing this bacteriocin
became the predominant member of a mixed culture in
which the other strain lacked the mcbABCI locus.
Results
M. catarrhalis strain E22 produces a factor that inhibits 
the growth of M. catarrhalis strain O35E
Wild-type  M. catarrhalis strain E22 was originally
described as the host for the plasmid pLQ510 [24]. As
reported previously [25], two of the ORFs in this plasmid
were predicted to encode products with similarity to pro-
teins involved in secretion of bacteriocins in other bacte-
ria. Upon testing the E22 strain in a bacteriocin
production assay using wild-type M. catarrhalis strain
O35E as the indicator strain, the growth of the indicator
strain was inhibited in the area immediately around the
E22 strain (Figure 1C). In control experiments, O35E did
not kill either itself (Figure 1A) or E22 (Figure 1B) and
E22 did not kill itself (Figure 1D). This result indicated
that strain E22 was capable of producing one or more fac-
tors that inhibited the growth of strain O35E.
Characterization of relevant protein products encoded by 
pLQ510
In a previous publication [25], ORF1 (now designated as
M. catarrhalis bacteriocin gene A or mcbA) in pLQ510 (Fig-
ure 1E) was described as encoding a protein with homol-
ogy to the colicin V secretion protein of E. coli [26]
whereas ORF2 (now designated mcbB) (Figure 1E)
encoded a protein that was most similar to the colicin V
secretion ATP-binding protein CvaB [26]. Analysis of the
similarities between the amino acid sequences of the
McbA and McbB proteins and those of proteins in
sequence databases was next assessed using BLAST [blastp
and PSI-BLAST [27]]. Both McbA and McbB were found to
be members of well-populated protein families. McbA
belongs to the HlyD family of so-called membrane-fusion
proteins (MFPs). These proteins form a periplasm-span-
ning tube that extends from an ABC-type transporter in
the plasma membrane to a TolC-like protein in the outer
membrane [28]. An alignment [29] of McbA to E. coli
HlyD showed that the two proteins are approximately
19% identical. Likewise, the primary structure of McbB is
similar to that of the E. coli protein HlyB protein; their
sequence identity is ~27%. HlyB is an ABC-type trans-
porter that is presumably dimeric. It has two mainBMC Microbiology 2009, 9:207 http://www.biomedcentral.com/1471-2180/9/207
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Killing of M. catarrhalis O35E by M. catarrhalis E22 carrying pLQ510 Figure 1
Killing of M. catarrhalis O35E by M. catarrhalis E22 carrying pLQ510. Test strains and indicator strains were grown on 
BHI agar plates as described in Materials and Methods. Panels: A, O35E test strain on O35E indicator; B, O35E test strain on 
E22 indicator; C, E22 test strain on O35E indicator; D, E22 test strain on E22 indicator. The white arrow in panel C indicates 
the zone of killing of the indicator strain by the test strain. Panel E, schematic of pLQ510 indicating the four ORFs located in 
the mcb locus. The nucleotide sequence of pLQ510 is available at GenBank under accession no. AF129811. The positions of the 
restriction sites used to insert kanamycin resistance cassettes in the mcbB and mcbC genes are indicated.
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domains: the N-terminal domain spans the plasma mem-
brane, facilitating the export of its cognate substrate, while
the C-terminal domain uses the energy of ATP hydrolysis
to drive the export of the substrate against a concentration
gradient [28]. Although the degree of sequence identity
between the M. catarrhalis and E. coli proteins is modest,
it is not unreasonable to assume that they may share anal-
ogous functions.
Identification of the M. catarrhalis bacteriocin and 
immunity factor genes
Immediately downstream from mcbB, two overlapping
and small putative ORFs were detected. The first of these,
designated  mcbC  (Figure 1E), contained 303-nt in
pLQ510 and was predicted to encode a protein containing
101 amino acids (Figure 2A). BLAST analysis showed that
this polypeptide had little similarity to other proteins or
known bacteriocins. However, examination of the
sequence of amino acids 25-39 in this protein revealed
that it was similar to the leader sequence of the double-
glycine (GG) bacteriocin family including E. coli colicin V
(CvaC) and other double-glycine peptides of both gram-
negative and gram-positive bacteria [30,31] (Figure 2B).
The second very small ORF was designated mcbI (Figure
1E) and overlapped the mcbC ORF, contained 225 nt, and
encoded a predicted protein comprised of 74 amino acids.
Similar to McbC, this small protein did not have signifi-
cant sequence similarity to other proteins in sequence
databases. Although the BLAST search algorithm can find
similar sequences, they are statistically poor (P ~ 0.925 for
McbC; P ~ 0.983 for McbI). Despite this fact, the results of
subjecting these sequences to the PSIPRED [32] second-
ary-structure prediction algorithm suggest that these pro-
teins are not simply random coils. This algorithm predicts
that approximately 50% of the residues of both of these
small proteins belong to a regular secondary structural
element. For McbI, the algorithm predicts four α-helices;
the average confidence score for residues with non-coil
predictions is 6.13, where 9 = highest confidence and 0 =
low confidence. The prediction for McbI is superior to that
for McbC. For McbC, the algorithm predicts seven β-
Putative bacteriocin proteins encoded by the mcb locus Figure 2
Putative bacteriocin proteins encoded by the mcb locus. (A) Amino acid sequence of the predicted McbC proteins 
encoded by the mcb locus in plasmid pLQ510, M. catarrhalis O12E, and M. catarrhalis V1120. Residues that differ among the 
proteins are underlined and bolded. (B) Alignment of the amino acid sequence of the putative leader of the M. catarrhalis O12E 
McbC protein with that of leader peptides of proven and hypothetical double-glycine peptides from other bacteria including 
CvaC [GenBank: CAA11514] and MchB [GenBank: CAD56170] of E. coli, NMB0091 [GenBank: NP_273152] of Neisseria men-
ingitidis, XF1219 [GenBank:AAF84029] and XF1694 [GenBank: AF84503] of Xylella fastidiosa and LafX [GenBank: AAS08589] of 
Lactobacillus johnsonii. Highly conserved amino acids are shaded with dark grey. This latter figure is adapted from that published 
by Michiels et al [30].
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pLQ510  MKYKKLPIALACNGNVSILNKEYIMRELLLDEVRSISGGSRWSVNGMGAINPNRLSYGGFNIGYNVNNQGISASANINVARIDGKTHWGDRGIMVGVTKKW
O12E                                          MRELLLDEVRSISGGSRWSVNG I GAINPNRLSYGSFNIGYNVNNQGISASANINVARIDGKTHWGDRGIMVGVTKKW
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strands and one α-helix; the average confidence score for
these secondary structural elements is 5.34. It is notewor-
thy that the PSIPRED algorithm predicts four α-helices for
McbI; the colicin E9 immunity factor is known to com-
prise three α-helices and one 310 helix [33].
Analysis of potential transcriptional linkage among the 
ORFs in the mcb locus
Reverse transcriptase-PCR was used to assess possible
linkage among the mcbA, mcbB, mcbC, and mcbI ORFs in
pLQ510. Primer pairs were designed to overlap the three
regions separating these ORFs (Figure 3A). RNA was iso-
lated from M. catarrhalis E22 in the logarithmic phase of
growth, reverse-transcribed, and then PCR-amplified
using these three pairs of oligonucleotide primers. Posi-
tive RT-PCR reactions were observed for all three sets of
primers (Figure 3B), indicating that these four ORFs are
likely transcribed together to yield a polycistronic mRNA
in M. catarrhalis E22.
The mcb locus is present in the chromosome of some M. 
catarrhalis wild-type strains
A total of 55 wild-type M. catarrhalis strains were tested in
the bacteriocin production assay with strain O35E as the
indicator strain. Thirteen strains (E22, V1120, V1156,
ETSU-5, ETSU-26, O12E, ETSU-22, ETSU-6, V1153, ETSU-
W-1, ETSU-25, FIN2341, and V1168) were found to
inhibit the growth of O35E (Figure 4A and Table 1). To
determine whether the mcbABCI  locus was present in
these strains, chromosomal DNA isolated from four of
Reverse transcriptase-PCR analysis of the mcbABCI locus in pLQ510 Figure 3
Reverse transcriptase-PCR analysis of the mcbABCI locus in pLQ510. (A) Schematic drawing showing the three sets 
of oligonucleotide primers that collectively spanned the three intergenic regions. (B) RT-PCR analysis of possible transcrip-
tional linkage among the ORFs in the mcbABCI locus in pLQ510. RT-PCR was carried out as described in Materials and Meth-
ods. Lanes 1, 4, and 7 contain PCR products derived from pLQ510 DNA. Lanes 2, 5, and 8 are RT-PCR negative controls in 
which M. catarrhalis E22 RNA was incubated in the absence of reverse transcriptase. Lanes 3, 6, and 9 show the products 
obtained when these same primer pairs were used in RT-PCR with RNA from M. catarrhalis E22. Size markers (in bp) are 
present on the left side of panel B.
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these putative bacteriocin-producing strains and from
four strains that did not inhibit strain O35E was used in
PCR with primers that would amplify a 3.2-kb product
spanning the mcbABC genes as found in pLQ510 (Figure
4B). All four of the bacteriocin-producing strains (Figure
4B, lanes 1-4) yielded the predicted 3.2-kb PCR product
whereas the four bacteriocin-negative strains (Figure 4B,
lanes 6-9) did not yield any detectable PCR product. Sub-
sequent plasmid DNA extraction from two of these bacte-
riocin-positive strains (O12E and V1120) showed no
plasmid DNA detectable by agarose gel electrophoretic
methods (data not shown), suggesting that the mcbABCI
locus in these strains was located in the chromosome.
The  mcbABCI  locus in both M. catarrhalis O12E and
V1120 was amplified by PCR and subjected to nucleotide
sequence analysis. Comparison of the nucleotide
sequence of the mcbA and mcbB ORFs from pLQ510 with
the nucleotide sequence of the corresponding ORFs in
O12E and V1120 showed at least 97% identity. Similarly,
the deduced amino acid sequences for each of the three
predicted McbA and McbB proteins were at least 98%
identical. The proteins predicted to be encoded by the
mcbC ORF in both pLQ510 and in the V1120 chromo-
some differed by only one amino acid (Figure 2A). How-
ever, the protein encoded by the mcbC ORF in strain O12E
was shorter by 24 aa than that encoded by the mcbC ORFs
in pLQ510 and V1120; this difference resulted from a
change in the predicted translational initiation codon in
Detection of bacteriocin production by wild-type M. catarrhalis strains Figure 4
Detection of bacteriocin production by wild-type M. catarrhalis strains. (A) Fifteen M. catarrhalis strains tested for 
bacteriocin production with strain O35E as the indicator strain. Thirteen of these strains were positive as shown here together 
with two negative strains (V1118 and O46E). (B) Agarose DNA gel electrophoretic analysis of PCR products obtained from 
four bacteriocin-positive strains (lane 1, ETSU-5; lane 2, FIN 2341; lane 3, O12E; lane 4, V1120) and 4 bacteriocin-negative 
strains (lane 6, FIN 2344; lane 7, O35E; lane 8, O46E; lane 9, V1118) with the oligonucleotide primers AA247 (binds within 
mcbA) and pLQ510-rp1 (binds within mcbC). Lane 5 contains a set of DNA size markers.
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Table 1: Bacterial strains and plasmids used in this study.
Bacterial Strains Description Bacteriocin Production Source or Reference
M. catarrhalis
O35E Wild-type strain - [54]
O35EΔmapA O35E mapA mutant, spectinomycin-resistant - [34]
E22 Wild-type strain containing plasmid pLQ510 + [24]
O12E Wild-type strain + [55]
O12E-Smr O12E rpsL mutant, streptomycin-resistant + [53]
O12EΔmcbA O12E with a deletion in the mcbA ORF - This study
O12E.mcbB::kan O12E with a kan cartridge inserted in the mcbB ORF - This study
O12EΔmcbB O12E with a deletion in the mcbB ORF - This study
O12E.mcbC::kan O12E with a kan cartridge inserted in the mcbC ORF - This study
O12EΔmcbC O12E with a deletion in the mcbC ORF - This study
V1069 Wild-type strain - Frederick Henderson
V1118 Wild-type strain - Frederick Henderson
V1120 Wild-type strain + Frederick Henderson
V1122 Wild-type strain - Frederick Henderson
V1126 Wild-type strain - Frederick Henderson
V1127 Wild-type strain - Frederick Henderson
V1129 Wild-type strain - Frederick Henderson
V1130 Wild-type strain - Frederick Henderson
V1145 Wild-type strain - Frederick Henderson
V1153 Wild-type strain + Frederick Henderson
V1156 Wild-type strain + Frederick Henderson
V1166 Wild-type strain - Frederick Henderson
V1168 Wild-type strain + Frederick Henderson
V1171 Wild-type strain - Frederick Henderson
ETSU-1 Wild-type strain - Steven Berk
ETSU-4 Wild-type strain - Steven Berk
ETSU-5 Wild-type strain + Steven Berk
ETSU-6 Wild-type strain + Steven Berk
ETSU-9 Wild-type strain - Steven Berk
ETSU-12 Wild-type strain - Steven Berk
ETSU-13 Wild-type strain - Steven Berk
ETSU-15 Wild-type strain - Steven Berk
ETSU-17 Wild-type strain - Steven Berk
ETSU-19 Wild-type strain - Steven Berk
ETSU-22 Wild-type strain + Steven Berk
ETSU-25 Wild-type strain + Steven Berk
ETSU-26 Wild-type strain + Steven Berk
ETSU-W-1 Wild-type strain + Steven Berk
FIN2265 Wild-type strain - Merja Helminen
FIN2284 Wild-type strain - Merja Helminen
FIN2341 Wild-type strain + Merja Helminen
FIN2344 Wild-type strain - Merja Helminen
FIN2404 Wild-type strain - Merja Helminen
FIN2405 Wild-type strain - Merja Helminen
FIN2406 Wild-type strain - Merja Helminen
FIN2421 Wild-type strain - Merja Helminen
FIN3423 Wild-type strain - Merja Helminen
FIN6467 Wild-type strain - Merja Helminen
FR2213 Wild-type strain - Richard Wallace
FR2336 Wild-type strain - Richard Wallace
FR3227 Wild-type strain - Richard Wallace
4223 Wild-type strain - [56]
7169 Wild-type strain - [57]
A221 Wild-type strain - Richard Wallace
A225 Wild-type strain - Richard Wallace
B59504 Wild-type strain - David Goldblatt
B59911 Wild-type strain - David Goldblatt
C2 Wild-type strain - [58]
C9 Wild-type strain - [58]BMC Microbiology 2009, 9:207 http://www.biomedcentral.com/1471-2180/9/207
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strain O12E (data not shown). The remaining 77 aa in the
O12E McbC protein differed by two residues from aa 25-
101 in the pLQ510 McbC protein and by one residue
from aa 25-101 in the V1120 McbC proteins (Figure 2A).
The proteins encoded by the mcbI ORFs from pLQ510,
O12E, and V1120 were identical.
Construction of in-frame deletion mutations in the mcb 
locus in strain O12E
The O12EΔmcbA mutant was constructed as described in
Materials and Methods, such that McbA amino acids 8-
411 are missing. PCR amplicons derived from the
mutated plasmids pLQ510.mcbB::kan  and
pLQ510.mcbC::kan  were used to transform O12E to
obtain kanamycin-resistant mcbB  and  mcbC  mutants.
These kanamycin-resistant transformants were then used
as targets for transformation by PCR amplicons that con-
tained in-frame deletions within the mcbB and mcbC ORFs
as described in Materials and Methods (Figure 5A). Strain
O12EΔmcbB  has McbB amino acids 8-685 deleted,
whereas strain O12EΔmcbC has McbC amino acids 3-68
deleted (Figure 5A). In contrast to the parent strain O12E
(Figure 5B, panel 1), each of these three mutants (Figure
5B, panels 2-4) was unable to kill strain O35E.
The mcbI gene encodes an immunity factor
To determine whether the mcbI gene encoded an immu-
nity factor, the mcbI gene from M. catarrhalis O12E was
cloned into the plasmid vector pWW115 to obtain
pAA113. A recombinant M. catarrhalis O35E strain con-
taining pAA113 with the cloned mcbI gene (Figure 5C,
panel 3) was resistant to killing by strain O12E. In con-
trast, both O35E (Figure 5C, panel 1) and O35E contain-
ing the empty vector pWW115 (Figure 5C, panel 2) were
killed by strain O12E.
Cloning and expression of the mcbC gene
The  M. catarrhalis O12E  mcbC  gene was cloned into
pWW115 and modified such that the encoded McbC pro-
tein contained six histidine residues at its C-terminus (as
described in Material and Methods). When expressed in
the O12E.mcbC::kan  mutant, the presence of this His-
tagged McbC protein allowed killing of strain O35E (Fig-
ure 6D), although the degree of killing appeared to be
slightly less than that obtained with the wild-type O12E
strain (Figure 6A). In contrast, neither the
O12E.mcbC::kan mutant (Figure 6B) nor this same mutant
containing only the pWW115 vector (Figure 6C) killed
O35E. Analysis of the purified His-tagged McbC protein
showed that it migrated in SDS-PAGE (Figure 6E, lane 1)
in a manner consistent with its calculated molecular
weight of ~7,600 (calculated for the fusion protein after
cleavage of the predicted leader sequence). This purified
His-tagged McbC protein did not kill O35E (data not
shown).
Competitive growth experiments
Two different sets of co-culture experiments were per-
formed to determine whether expression of the McbC bac-
teriocin would confer a growth advantage on a M.
catarrhalis  strain containing the mcbABCI  locus. In the
first, the bacteriocin-producing, streptomycin-resistant
strain O12E-Smr and the spectinomycin-resistant, bacteri-
ocin-sensitive mutant O35EΔmapA [34] were mixed at a
ratio of approximately 1:1 and grown in broth for 18 h. At
the end of this growth period, O12E-Smr was the vastly
predominant member (avg. 98.5%) of this culture. In a
second set of experiments, O12E-Smr  was co-cultured
(starting inoculum ratio of 1:1) with either O35E contain-
ing the pWW115 vector or the recombinant plasmid
pAA113 containing the wild-type O12E mcbI gene encod-
ing the immunity factor. When O12E-Smr was grown
overnight with O35E(pWW115), the bacteriocin-produc-
ing strain became predominant (avg. 99.76%) in the cul-
ture. In contrast, when the O35E strain expressed the mcbI
gene product from a multi-copy plasmid, this recom-
binant strain persisted in the presence of the bacteriocin-
producing strain such that M. catarrhalis O35E(pAA113)
cells represented 76.9% of the total cells in the culture. It
should be noted that, when all four of these strains were
cultured independently in broth for 7-8 h, the O12E-Smr
strain was shown to grow at approximately the same rate
and to approximately the same extent as the other three
strains (data not shown).
MC317 Wild-type strain - [59]
O46E Wild-type strain - [10]
P44 Wild-type strain - [58]
Plasmids
pLQ510 Plasmid from M. catarrhalis E22 + [24]
pLQ510.mcbB::kan pLQ510 with a kan cartridge inserted within the mcbB ORF - This study
pLQ510.mcbC::kan pLQ510 with a kan cartridge inserted within the mcbC ORF - This study
pWW115 Cloning vector for M. catarrhalis, spectinomycin-resistant - [52]
pAA111 pWW115 expressing a cloned His-tagged McbC protein + This study
pAA113 pWW15 expressing the wild-type McbI protein - This study
Table 1: Bacterial strains and plasmids used in this study. (Continued)BMC Microbiology 2009, 9:207 http://www.biomedcentral.com/1471-2180/9/207
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Analysis of mutant and recombinant M. catarrhalis strains Figure 5
Analysis of mutant and recombinant M. catarrhalis strains. (A) Schematic showing the mcbABCI locus in the O12E 
chromosome and the position of the oligonucleotide primers used to construct the three different in-frame deletion mutations 
in this locus. The extent of the deletion in each ORF is indicated. (B) Bacteriocin production assay using O35E as the indicator 
strain together with the following test strains: panel 1, O12E; panel 2, O12EΔmcbA; panel 3, O12EΔmcbB; panel 4, O12EΔmcbC. 
Panel C, Use of recombinant M. catarrhalis strains to demonstrate that expression of McbI in O35E confers protection against 
killing by strain O12E. M. catarrhalis O12E was used as the test strain in a bacteriocin production assay with three different M. 
catarrhalis strains as the indicator. Panels: A, O35E wild-type; B, O35E(pWW115) [vector-only control]; C, O35E(pAA113) 
[expressing McbI].
O12EmcbA
O12EmcbB
O12EmcbC
1                  2                  3                   4
O12EmcbA
O12EmcbB
O12EmcbC
1                  2                  3                   4
A
B
O12EmcbA
O12EmcbB
O12EmcbC
1                  2                  3                   4
O12EmcbA
O12EmcbB
O12EmcbC
1                  2                  3                   4
A
B
O12E
O35E
O35E(pAA113)
O35E(pWW115)
1                         2                        3
CBMC Microbiology 2009, 9:207 http://www.biomedcentral.com/1471-2180/9/207
Page 10 of 15
(page number not for citation purposes)
Discussion
Bacteriocins are proteins and peptides that are ribosoma-
lly synthesized by many bacterial species and which usu-
ally have bactericidal activity against the same species or
closely related bacteria. Bacteriocins range in size from the
relatively large colicins (~60 kDa) synthesized by some E.
coli  strains to the very small (< 5 kDa) microcins [for
reviews see [22,30,35]]. A significant number of bacterioc-
ins, and especially those produced by lactic acid bacteria,
have been studied for their potential to be used in food
preservation [36]. The bacteriocins produced by the lactic
acid bacteria are divided into two general classes. Class I
bacteriocins undergo post-translational modification
whereas class II microcins do not. These class II bacterioc-
ins also have a characteristic leader sequence containing a
double-glycine (GG) motif which is cleaved on the C-ter-
minal side to release the mature bacteriocin [for a review
see [35]].
In this study, we report the identification of a bacteriocin
produced by M. catarrhalis. Despite the fact that the amino
acid sequence of the mature McbC peptide did not show
any significant homology to known bacteriocins, the
sequence of the first 15 amino acids of the M. catarrhalis
O12E McbC protein shows a high degree of conservation
with leader peptides of proven and hypothetical class II
bacteriocins from other bacteria (Figure 2B). The pre-
dicted McbC proteins encoded by the pLQ510 plasmid
(in  M. catarrhalis strain E22) and M. catarrhalis strain
V1120, however, were both longer than the predicted
O12E McbC protein, containing an additional 24 aa at the
N-terminus. Because all three of these strains expressed
killing activity against O35E, it appears that the shorter
version of the McbC protein is functional with respect to
bactericidal activity. Examination of the nucleotide
sequence of the region preceding the two possible McbC
translation initiation codons in both pLQ510 and V1120
Expression of the His-tagged mcbC gene product Figure 6
Expression of the His-tagged mcbC gene product. Killing of strain O35E by (A) wild-type O12E, (B) O12E.mcbC::kan; (C) 
O12E.mcbC::kan(pWW115); (D) O12E.mcbC::kan(pAA111). (E) Western blot-based detection of His-tagged McbC protein 
purified from spent culture supernatant fluid from (lane 1) M. catarrhalis O12E.mcbC::kan(pAA111) and (lane 2) M. catarrhalis 
O12E.mcbC::kan(pWW115) (negative control). A His-tag specific antibody was used as the primary antibody for Western blot 
analysis. Molecular weight position markers (in kDa) are present on the left side of this panel.
O12E O12E.mcbC::kan
O12E.mcbC::   
kan(pAA111)
O12E.mcbC::     
kan(pWW115)
O12E O12E.mcbC::kan
O12E.mcbC::   
kan(pAA111)
O12E.mcbC::     
kan(pWW115)
O12E.mcbC::kan(pWW115)
O12E.mcbC::kan(pAA111)
16
6
16
6
A B
CD
E
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indicated that the better predicted Shine-Dalgarno site
was located immediately upstream of the second ATG
(data not shown); this is the same ATG predicted to be the
translation initiation codon for the O12E mcbC  ORF.
Export of class II bacteriocins involves both an ATP-bind-
ing cassette (ABC) transporter and an accessory protein
belonging to the membrane-fusion protein family [30].
The former protein also possesses proteolytic activity in an
N-terminal domain [37] which belongs to the C39 pepti-
dase superfamily [for a review see [31]]. The genes encod-
ing both of these membrane-bound proteins are
frequently located together with the ORFs encoding the
bacteriocin and the host immunity factor [38]. Reverse
transcriptase-PCR analysis of the locus in pLQ510 con-
taining the gene encoding the McbC bacteriocin (Figure
3) indicated that it is located in an operon where it is pre-
ceded by the mcbA and mcbB genes which encode a pre-
dicted accessory protein (McbA) belonging to the
membrane-fusion family and an ABC transporter (McbB),
respectively. A previous BLAST-based survey identified the
protein encoded by mcbB as an ABC transporter, although
no more detailed analysis of this protein was provided by
these authors [30].
The 3'-end of the mcbC gene is overlapped by the 5'-end of
another ORF which encodes the immunity factor McbI.
Similar ORF overlaps, described previously for other bac-
teriocin-producing systems, would allow tight co-regula-
tion of the production of the bacteriocin and its cognate
immunity factor [39,40]. The function of the McbI protein
was deduced from an experiment in which the presence of
the  mcbI  gene on a multi-copy plasmid protected the
McbC-sensitive O35E strain from killing by the McbC-
producing O12E strain (Figure 5C). The McbI protein
contains only 74 amino acids and did not show a high
degree of amino acid sequence homology to other immu-
nity proteins, a result which is not unusual [39]. However,
the predicted secondary structure of McbI showed the
presence of four α-helices, a feature that is conserved
among class IIa immunity proteins [35,41]. Precisely how
the immunity protein confers protection against its cog-
nate bacteriocin has been elucidated for at least one class
II bacteriocin [42].
While the mcbABCI locus was first identified in the plas-
mid pLQ510, the ability to kill O35E was not restricted to
the E22 strain carrying this plasmid. Instead, 12 of
another 54 M. catarrhalis strains tested in the present study
could kill O35E. Moreover, the presence of the bacteriocin
locus in at least some of these other M. catarrhalis strains
is apparently not dependent on the presence of an extra-
chromosomal element. Two M. catarrhalis strains (O12E
and V1120) which were able to kill O35E also had the
mcbA, mcbB, and mcbC genes located in their chromosome
in the absence of any plasmids detectable by a basic plas-
mid isolation technique. In this regard, it is interesting to
note that the original report describing the existence of
pLQ510 in strain E22 indicated that some pLQ510 plas-
mid sequences were detected by Southern blot analysis in
the chromosome of another M. catarrhalis strain that
apparently lacked plasmids [24].
Efforts to obtain killing activity with filter-sterilized, spent
culture supernatant fluids from a M. catarrhalis strain con-
taining the mcbABCI locus were not successful (data not
shown). It is interesting that the killing zone produced by
the strains carrying the mcbABCI locus is very small (Fig-
ure 1C and Figure 4A). It is possible that the in vitro
growth conditions used in this study were not optimal for
bacteriocin production by M. catarrhalis, and that there
may exist an environmental signal which will increase
synthesis and release of this bacteriocin. Other bacterioc-
ins can often be concentrated from spent culture superna-
tant fluids [43-45], and it is difficult to explain our
inability to accomplish this with the McbC protein. Simi-
larly, a purified, His-tagged McbC protein was not able to
kill a sensitive strain in vitro (data not shown). Whether
the quantity of purified McbC protein was insufficient,
whether the purification procedure inactivated this fusion
protein, or whether the His tag may have interfered with
McbC bactericidal activity cannot be determined from the
available data.
The true biological role of the McbC bacteriocin remains
to be determined. Results presented in the present study
suggest that the McbC protein likely has a relatively nar-
row range of activity, apparently being only able to kill M.
catarrhalis  strains that are lacking the mcbABCI  locus.
Expression of McbC might mediate some type of intraspe-
cies competition in the nasopharynx, as has been
described for the BlpMN bacteriocins of Streptococcus
pneumoniae  [46]. In addition, inactivation of a gene
involved in bacteriocin production in Neisseria meningi-
tidis was recently shown to adversely affect the ability of
the mutant to colonize in a human nasal pharyngeal
organ culture model [47].
In a preliminary effort to determine whether McbC might
be able to kill other members of the normal flora of the
human oropharynx and thereby facilitate colonization of
the mucosa by M. catarrhalis, we performed growth inhi-
bition experiments using two different α-hemolytic strep-
tococci [Streptococcus mitis NS 51 (ATCC 49456) and the
Streptococcus sanguinis type strain (ATCC 10556)] as the
indicator strains. However, M. catarrhalis O12E had no
detectable inhibitory effect on the growth of these two
strains (data not shown). The limited spectrum of killing
activity for McbC also raises the possibility that it might
serve to lyse other M. catarrhalis strains that lack the mcbA-BMC Microbiology 2009, 9:207 http://www.biomedcentral.com/1471-2180/9/207
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BCI locus, thereby making their DNA available for lateral
gene transfer via transformation of the strain containing
the  mcbABCI  operon. A similar mechanism has been
described for how Streptococcus mutans might use its
mutacin (bacteriocin) to acquire genes from closely
related streptococcal species in vivo [48].
Conclusion
Approximately 25% of the M. catarrhalis strains tested in
this study produced a bacteriocin that could kill strains of
this pathogen that lacked the mcbABCI locus. Expression
of the gene products encoded by this locus conferred a
competitive advantage in vitro over a strain that did not
possess this set of genes. Whether this bacteriocin is
expressed in vivo (i.e., in the human nasopharynx)
remains to be determined, but production of this bacteri-
ocin could facilitate lateral gene transfer among M.
catarrhalis strains.
Methods
Bacterial strains, plasmids and growth conditions
Bacterial strains and plasmids used in this study are listed
in Table 1. Moraxella catarrhalis strains were routinely
grown in brain heart infusion (BHI) broth (Difco/Becton
Dickinson, Sparks, MD) with aeration at 37°C, or on BHI
solidified using 1.5% (wt/vol) agar. When appropriate,
BHI was supplemented with kanamycin (15 μg/ml),
streptomycin (100 μg/ml), or spectinomycin (15 μg/ml).
BHI agar plates were incubated at 37°C in an atmosphere
containing 95% air-5% CO2. Mueller-Hinton (MH) broth
(Difco/Becton Disckinson) was used for some growth
experiments involving co-culture of two different M.
catarrhalis strains. Streptococcus mitis NS 51 (ATCC 49456)
and the Streptococcus sanguinis type strain (ATCC 10556)
were obtained from the American Type Culture Collection
(Manassas, VA) and were grown on blood agar plates.
Detection of bacteriocin production
M. catarrhalis strains were tested for bacteriocin produc-
tion by growing both the test strain (i.e., the putative bac-
teriocin-producing strain) and the indicator strain (i.e.,
the putative bacteriocin-sensitive strain) separately in BHI
broth overnight at 37°C. The cells of the indicator strain
were collected by centrifugation and resuspended in a 5
ml portion of BHI to an OD600 = 0.25. The cells of the test
strain were collected by centrifugation and resuspended in
a 1 ml volume of BHI. A 250-μl portion of the suspension
of the indicator strain was used to inoculate a flask con-
taining 25 ml of molten BHI agar [0.8% (wt/vol) agar] at
a temperature of 45°C. A 10-ml portion of the inoculated
molten BHI agar was then spread over approximately 20
ml of solidified BHI agar in a Petri dish. The plates were
allowed to solidify and then 10-μl portions of the test
strain suspension were spotted on the surface of the agar.
These plates were then incubated at 37°C overnight. Pro-
duction of bacteriocin by the test strain and/or the suscep-
tibility of the indicator strain were indicated by the
presence of a small clear zone of growth inhibition
around the test strain.
PCR-based detection of the mcb locus
Chromosomal DNA was prepared from eight M. catarrha-
lis strains and used in PCR with the oligonucleotide prim-
ers AA247 (5'-TGCCATTGCCAAAGAGAC-3') and
pLQ510-rp1 (5'-CACCATATGACAATCTATTAG-3').
AA247 was located in the mcbA ORF and pLQ510-rp1 was
located in the mcbC ORF. Nucleotide sequences of the
mcbABCI  genes from M. catarrhalis strain O12E were
deposited at GenBank and assigned the following acces-
sion numbers: mcbA, EU780917; mcbB, EU780918; mcbC,
EU780919; mcbI, EU780920. The mcbABCI genes from M.
catarrhalis strain V1120 were deposited at GenBank and
assigned the following accession numbers: mcbA,
EU755328;  mcbB, EU755329;  mcbC, EU755330;  mcbI,
EU755331.
Inactivation of selected genes in pLQ510
The mcbB ORF was inactivated by ligating a kanamycin
resistance cassette [49] into the BsiWI site within this ORF
in pLQ510; the new plasmid was designated
pLQ510.mcbB::kan. The mcbC  ORF was inactivated by
inserting a kanamycin resistance cassette into the HpaI
site in this ORF; the new plasmid was designated
pLQ510.mcbC::kan.
Construction of deletion mutations in the chromosome of 
M. catarrhalis strain O12E
To construct an in-frame deletion in the mcbA gene, prim-
ers AA262 (5'- GAAGT AAATCGTCAGATGG-3') and
AA349 (5'-AGGGCGGAATAGACTAGACAT-3') were used
to amplify a DNA fragment containing the 345 nucle-
otides (nt) upstream of the mcbA ORF together with the
first 21 nt of this ORF, using chromosomal DNA from
strain O12E as a template. Primers AA350 (5'-AGTCTAT-
TCCGCCCTCCGCT ATATAGT CTCACAGGTAAAATT-
TAA-3') and AA250 (5'-AAAACTGGCTGG GCAGATG-3')
w e r e  u s e d  t o  a m p l i f y  t h e  l a s t  3 0  n t  o f  t h e  mcbA  ORF
together with 855 nt of the downstream DNA. The result-
ant two PCR products were used as templates in overlap-
ping extension PCR [50] using primers AA262 and AA250.
The new PCR product was used in a plate transformation
system [51] to transform M. catarrhalis strain O12E. Trans-
formants were screened by colony-PCR using primers
AA262 and AA251 (5'-AGATTGCTCACTCGTCCAC-3');
this latter primer binds downstream of AA250. One trans-
formant shown to contain the desired deletion in the
mcbA gene was designated O12EΔmcbA.
For the construction of an in-frame deletion in the mcbB
ORF, primers AA247 (5'-TGCCATTGCCAAAGAGAC-3')BMC Microbiology 2009, 9:207 http://www.biomedcentral.com/1471-2180/9/207
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and AA346 (5'-AATATTCTTTAAAAAATC CAT-3') were
used to amplify 830 nt upstream of the mcbB  ORF
together with the first 21 nt of the mcbB ORF using chro-
mosomal DNA from strain O12E as the template. In addi-
tion, primers AA347 (5'-TTTTTAAAGAATATTAGCACTGA
TT GGGTACTGAACCTTGGTTAA-3') and AA254 (5'-
GGGCTTTGGGCGGTA GGTTATTA-3') were used to
amplify the last 30 nt of the mcbB ORF and 769 nt of the
downstream region. Both PCR fragments were used as
templates for an overlapping extension PCR using primers
AA247 and AA254; the resultant amplicon was designated
247-254. Wild-type strain O12E was first transformed
with a PCR amplicon obtained by using primers AA248
(5'-CTGTTGCCAAAACTGCTC-3') and AA252 (5'-GCA-
CATTGTTCCACCCATTCA-3') with plasmid
pLQ510.mcbB::kan  as the template; this amplicon con-
tained the mcbB gene and the inserted kan cartridge. One
of the resultant kanamycin-resistant transformants
(O12E.mcbB::kan) was subsequently transformed with the
247-254 amplicon. Transformants were screened for the
loss of kanamycin resistance and one kanamycin-sensitive
transformant was selected for further study and desig-
nated as O12EΔmcbB.
To construct an in-frame deletion in the mcbC ORF, the
same strategy was employed as was used for construction
of the O12EΔmcbB mutant. The primer pair AA249 (5'-
TTAGACCC AAGTGCTGGAC-3') and AA344 (5'-ACG-
CATAATATATTCCTTT AT-3') and the primer pair AA345
(5'-GAATATATTATGCGTATTATGGTTG GAGT-
TACTAAAAAATGGTAA-3') and AA254 were used in the
initial PCR reactions with O12E chromosomal DNA, and
the final amplicon containing a deletion in the mcbC ORF
was used to transform an O12E mutant which had a kan-
amycin resistance cassette in its mcbC  ORF (i.e.,
O12E.mcbC::kan). One kanamycin-sensitive transformant
was selected for further characterization and was desig-
nated O12EΔmcbC. PCR and nucleotide sequence analysis
were used to confirm that these three deletion mutations
(i.e., in O12EΔmcbA, O12EΔmcbB, and O12EΔmcbC) were
in-frame.
Reverse transcriptase-PCR
Possible transcriptional linkage among the ORFs in the
mcb locus in pLQ510 was assessed by the use of reverse
transcriptase-PCR. Total RNA was isolated from mid-log-
arithmic phase cells of M. catarrhalis E22 by using the
RNeasy midi kit (Qiagen). RNA samples were treated with
DNase I (Message Clean Kit, GenHunter Corp, Nashville,
TN) to remove any DNA contamination. To amplify the
region between the mcbA and mcbB ORFs, primers mcb A/
B fw (5'-TAGCAGTTGGCATGACC TTG-3') and mcb A/B rv
(5'-AGCAAGACAGGCTAGACCACA-3') were used. For
the region between mcbB and mcbC, primers mcb B/C fw
(5'-AGAGCGCTGATTG GGTACTG-3'), and mcb  B/C rv
(5'-CAT GCCATTGACTGACCAAC-3'), were used, and for
the region between mcbC and mcbI, primers mcb C/I fw
(5'-TCCTA ATAGATTGTCATATGGTGGTT-3') and mcb C/I
rv (5'-CAAAACG TGCACA ATTAGGG-3') were used. The
reverse transcriptase reaction was carried out using Multi-
Scribe reverse transcriptase (Applied Biosystems, Foster
City, CA) followed by PCR amplification. In addition, the
reaction was also performed using either chromosomal
DNA alone as the template or with the RNA template in
the absence of reverse transcriptase.
Construction of a plasmid encoding a His-tagged McbC 
protein
In order to construct a plasmid that expressed the McbC
protein with a C-terminal His-tag, the primer pair AA357
(5'-TGGGATCCGGTACTATTTAATGTACTAA GATTTT-3')
(BamHI site underlined) and AA359 (5'-GTGGTGGT-
GGTGGTGGTG CCATTTTTTAGTAACTCCAACCATAAT-
3') and the primer pair AA358 (5'-CACCACCACCACCAC-
CACTAAAGACAATAGGTTTAGCATGGATAT-3') (mcbC
translational stop codon underlined) and AA354 (5'-
GGTTGAGCTCCCA TTTAAGTGATTTTGTTATATCAAT-3')
(SacI site underlined) were used to generate two PCR
products using O12E chromosomal DNA as the template.
The resultant two PCR products were used as templates for
an overlapping extension PCR involving primers AA357
and AA354. The final PCR amplicon was then digested
with both BamHI and SacI and ligated into pWW115 [52]
that had been digested with these same restriction
enzymes. The ligation mixture was used to transform
O12E.mcbC::kan. A plasmid isolated from a spectinomy-
cin-resistant colony and which expressed the His-tagged
McbC protein was designated pAA111. Plasmid pWW115
was used to transform M. catarrhalis O12E.mcbC::kan to
provide a negative control.
Purification and detection of the His-tagged McbC protein
M. catarrhalis O12E.mcbC::kan(pWW115) and M. catarrh-
alis O12E.mcbC::kan(pAA111) were grown independently
in 1 L BHI overnight at 37°C with shaking. The cultures
were subjected to centrifugation to pellet the bacterial
cells and the supernatant fluid was filter-sterilized. Two
columns each containing 1.5 mL of NiNTA agarose beads
(Qiagen, Valencia, CA) were washed with washing buffer
(50 mM NaH2PO4, 200 mM NaCl, 5 mM imidazole [pH
7.9]). The culture supernatant fluids were passed through
the columns twice after which the columns were washed
with washing buffer again. The His-tagged protein was
eluted using elution buffer (50 mM NaH2PO4, 200 mM
NaCl, 200 mM imidazole [pH 7.9]). Selected fractions
were pooled and dialyzed against PBS. SDS-digestion
buffer was added to a final concentration of 1× to each
sample. For Western blot analysis, proteins were resolved
by SDS-PAGE using 15% (wt/vol) polyacrylamide sepa-
rating gels and transferred to polyvinylidene difluorideBMC Microbiology 2009, 9:207 http://www.biomedcentral.com/1471-2180/9/207
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membranes. The anti-His tag antibody HIS.H8 (Millipore,
Temecula, CA) was used at a dilution of 1:2,000 in PBS-
Tween containing 3% (wt/vol) dried milk and incubated
with the membrane for 2 h at room temperature. Horse-
radish peroxidase-conjugated goat anti-mouse antibody
(Jackson Immunoresearch, West Grove, PA) was used as
the secondary antibody. The antigen-antibody complexes
were detected by using Western Lightning Chemilumines-
cence Reagent Plus (New England Nuclear, Boston, MA).
Construction of a plasmid containing the mcbI gene
Primers AA353 (5'-ATGGATCCGAAAACTCATTGGGGA-
GATAGAGGGAT-3') (BamHI site underlined) and AA378
(5'-TTGTGAGCTCGCTCGGATTTGCTATTATTGA-3')
(SacI site underlined) were used to PCR-amplify a 288-bp
fragment containing the mcbI  gene from M. catarrhalis
O12E chromosomal DNA. The resultant PCR product was
digested with both BamHI and SacI and ligated into
pWW115 which had been digested with the same two
restriction enzymes. This ligation mixture was used to
transform M. catarrhalis strain O35E and transformants
were selected for spectinomycin resistance. The plasmid
from one of these transformants was designated pAA113.
Competitive index-based broth growth experiments
A streptomycin-resistant mutant of the wild-type strain
O12E (O12E-Smr) [53] and the spectinomycin-resistant
recombinant strains O35E(pWW115) and
O35E(pAA113) were grown separately in MH broth to a
density of approximately 108 CFU/ml. Equal volumes of
O12E-Smrand the individual recombinant O35E strains
were mixed in a 1:1 ratio. Serial dilutions of this mixture
were plated on BHI agar plates containing the appropriate
antibiotic to determine the relative percentages of each
strain in the input mixture. Either a 1 ml or a 0.5 ml por-
tion of the mixture was used to inoculate either 250 ml or
125 ml of MH broth, respectively, which was then allowed
to grow overnight at 37°C with aeration. The cells were
harvested after 18 h of growth, serially diluted, and plated
on agar-based media containing the appropriate antibi-
otic to determine the relative percentage of each strain in
the output mixture. A second set of competition experi-
ments involving O12E-Smr and the spectinomycin-resist-
ant mutant O35EΔmapA  [34] was performed similarly.
Each co-culture experiment was done three times inde-
pendently; the data are the mean of the three experiments.
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